×

Stocks Walgreens Boots Alliance Inc

  • CAMP HILL, Pa.-- Rite Aid Corp.' s revenue from established locations slid less than 1 percent last month, as the introduction of cheaper generic drugs helped knock down pharmacy sales for the nation's third largest drugstore chain.

  • *Sales at Costco and Gap top expectations. *Macy's, Target, Kohl's sales miss analysts' forecasts. "I think September overall is going to be OK; I don't think it's going to be great," said John Rooney, national retail& distribution sector lead for Deloitte Consulting.

  • *Macy's, Target sales miss analysts' forecasts. Retailers including Costco Wholesale Corp, Victoria's Secret operator Limited Brands Inc and teen chain Zumiez Inc posted bigger-than-expected gains in September sales at stores open at least a year. Target Corp and Macy's Inc posted same-store sales increases that missed analysts' expectations.

  • *Sales from Costco, Limited, Zumiez top expectations. Retailers including Costco Wholesale Corp and Victoria's Secret operator Limited Brands Inc posted bigger-than-expected gains in September sales at stores open at least a year.

  • Oct 3- Fitch Ratings has assigned a' BBB+' rating to the $350 million aggregate principal amount 2.00% coupon senior unsecured notes due 2018 and $450 million aggregate principal amount 3.25% coupon senior unsecured notes due 2022 issued by Realty Income Corporation. Fitch currently rates Realty Income as follows:.

  • market-insider-stocks-to-watch-200.jpg

    Take a look at some of Wednesday's midday movers:

  • U.S. stocks advanced on Wednesday after stronger-than-expected employment and service-sector data in the United States. But a gloomier outlook in China and Europe weighed on commodity prices and hit energy and materials shares. **SAREPTA THERAPEUTICS INC, $41.60, up 177 pct.

  • U.S. stocks rose on Wednesday after stronger-than-expected employment and service-sector data in the United States, but a gloomier outlook in China and Europe weighed on commodity prices and hit energy and materials shares. **SAREPTA THERAPEUTICS INC, $40.65, up 171 pct. **HEWLETT-PACKARD CO, $15.67, down 8.4 pct.

  • **SAREPTA THERAPEUTICS INC, $40.19, up 168 pct. **BIOLASE INC, $2.11, up 27 pct. The company said health regulators in Europe and the United States approved its laser device for use in soft tissue surgery, teeth whitening, and pain therapy.

  • The Nasdaq Composite Index rose 0.37 percent. **SAREPTA THERAPEUTICS INC, $30.30, up 102 pct. **INTERMUNE INC, $9.74, up 10 pct.

  • **SAREPTA THERAPEUTICS INC, Tuesday close $14.99, up 135 pct premarket. **HEWLETT-PACKARD CO, Tuesday close $17.13, up 0.4 pct premarket. **GOOGLE INC, Tuesday close $756.99, up 0.13 pct premarket.

  • **SAREPTA THERAPEUTICS INC, Tuesday close $14.99, up 135 pct premarket. **HEWLETT-PACKARD CO, Tuesday close $17.13, up 0.4 pct premarket. **GOOGLE INC, Tuesday close $756.99, up 0.13 pct premarket.

  • **SAREPTA THERAPEUTICS INC, Tuesday close $14.99, up 135 pct premarket. **INTERMUNE INC, Tuesday close $8.85, up 10.7 pct premarket. **B&G FOODS INC, Tuesday close $33.51, down 8.4 pct premarket.

  • *Walgreens September sales decrease 7.8 percent. *September sales fell 7.8 percent to $5.48 billion. *Says September total front-end sales decreased 0.4 percent compared with the.

  • NEW YORK, Oct 2- Dutch brewer Heineken raised US $3.25 bn from a four-part bond offering in style by establishing a new record for the lowest coupon paid by a Triple B issuer for three- and five-year bonds. The company was in the market to take out a EUR2.5bn bridge loan for its acquisition of Asia Pacific Breweries.

  • jim-cramer-fb2-200.jpg

    Executives who realize they have to do something to improve their fortunes are being rewarded, Cramer said.

  • Stocks closed higher for a third-straight session in choppy trading Thursday, with the S&P 500 hitting its best level since May.

  • U.S. stock index futures pared some of its earlier gains Thursday after the weekly jobless claims rose more than expected and as investors digested a bag of mixed earnings reports.

  • 308120-001_opt.jpg

    The United States is a ‘paradise’ compared to the rest of the world and investors should be looking at companies that make most, if not all, of their money in the country because these firms will be able to weather a downturn in the global economy a lot better, according to Bill Smead, CEO of Smead Capital Management.